Lonza Bioscience Cell & Gene Tech Expo April 2026: Cell Therapy
Learn about the new 4D-Nucleofector® LV Unit PRO, Lonza's next-generation large-scale electroporation platform, designed to deliver clinically relevant cargos into large volumes of T cells for CAR-T development.
Join for a technology introduction and a short dive into selected data sets demonstrating the technology's enhanced performance for CRISPR-based knock-out, knock-in, and transposon-based integration.
About Lonza Bioscience
Lonza’s Cell & Gene offering spans across development and manufacturing services, products, testing and automation platforms, as well as tools and technologies to enable you to develop, de-risk, and industrialize your therapy, from basic research to commercialization.
United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence, and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.